Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2013 1
2015 1
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Maretbayeva SM, et al. Among authors: adenov mm. Int J Infect Dis. 2021 Dec;113 Suppl 1:S91-S95. doi: 10.1016/j.ijid.2021.03.075. Epub 2021 Apr 3. Int J Infect Dis. 2021. PMID: 33823277 Free article.
HIV and multidrug-resistant tuberculosis: overlapping risk factors.
van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Ismailov S. van den Hof S, et al. Among authors: adenov m. Eur Respir J. 2015 Feb;45(2):567-9. doi: 10.1183/09031936.00131014. Eur Respir J. 2015. PMID: 25653273 Free article. No abstract available.
Safety of treatment regimens containing bedaquiline and delamanid in the endTB cohort.
Hewison C, Khan U, Bastard M, Lachenal N, Coutisson S, Osso E, Ahmed S, Khan P, Franke MF, Rich ML, Varaine F, Melikyan N, Seung KJ, Adenov M, Adnan S, Danielyan N, Islam S, Janmohamed A, Karakozian H, Kimenye MK, Kirakosyan O, Kholikulov B, Krisnanda A, Kumsa A, Leblanc G, Lecca L, Nkuebe M, Mamsa S, Padayachee S, Thit P, Mitnick CD, Huerga H; endTB study observational study team. Hewison C, et al. Among authors: adenov m. Clin Infect Dis. 2022 Jan 13:ciac019. doi: 10.1093/cid/ciac019. Online ahead of print. Clin Infect Dis. 2022. PMID: 35028659
Corrigendum to 'Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis' International Journal of Infectious Diseases Volume 113S1 (2021) S91-S95.
Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Maretbayeva SM, et al. Among authors: adenov mm. Int J Infect Dis. 2022 Aug;121:105. doi: 10.1016/j.ijid.2022.05.004. Epub 2022 May 23. Int J Infect Dis. 2022. PMID: 35613479 Free article. No abstract available.